Target intelligence / Profile preview

Oxidative stress regulators

Molecular classification
Enzyme, Transcription factor, Transporter, Other
01

Overview

Oxidative stress regulators represent a broad functional category of molecular entities, including enzymes, transcription factors, and small molecules, that maintain cellular redox homeostasis by balancing reactive oxygen species (ROS) production and antioxidant defense [3, 12]. The master regulator in humans is the transcription factor Nrf2 (NFE2L2), which induces the expression of cytoprotective genes such as heme oxygenase-1 (HO-1) and superoxide dismutase (SOD) [3, 9, 14]. Other critical components include enzymes like catalase and glutathione peroxidase that directly neutralize hydrogen peroxide and lipid hydroperoxides [1, 14]. Dysregulation of these systems leads to oxidative stress, causing damage to DNA, proteins, and lipids, which is implicated in cancer, neurodegeneration, and cardiovascular diseases [3, 12, 15]. Pharmacological strategies include Nrf2 activators like bardoxolone methyl and dimethyl fumarate, as well as ROS scavengers and enzyme mimetics like edaravone [6, 13, 14]. However, therapeutic development is challenged by the need to avoid "reductive stress," which occurs when excessive antioxidant activity disrupts essential physiological ROS signaling [3, 7].

Other names
Antioxidant defense systemRedox regulatorsROS scavengersAntioxidant enzymesRedox signaling molecules
02

Mechanism of action

Activation of the Nrf2-Keap1 pathway to induce antioxidant gene expression; direct scavenging of reactive oxygen species (ROS); inhibition of ROS-generating enzymes such as NADPH oxidase or xanthine oxidase; and mimetic activity of endogenous enzymes like superoxide dismutase or glutathione peroxidase [3, 6, 14].

03

Biological functions

Redox homeostasisOxidative stress responseApoptosisSignal transductionCell proliferationCell deathImmune response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesAgingInfection
05

Safety considerations

Risk of reductive stressInterference with physiological ROS signalingPotential for pro-oxidant effects at high concentrationsOff-target effects of broad-spectrum antioxidants [3, 7, 14].
06

Interacting drugs

Bardoxolone methyl

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH/GSSG ratio)4-Hydroxynonenal (4-HNE)Protein carbonylsIsoprostanes [1, 2, 5, 8].

Beyond the preview

Go deeper on Oxidative stress regulators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidative stress regulators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call